• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振弥散加权成像在头颈部鳞癌放化疗中的预测价值。

Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma.

机构信息

Department of Radiology, University Hospitals Leuven, Leuven, Belgium.

出版信息

Eur Radiol. 2010 Jul;20(7):1703-14. doi: 10.1007/s00330-010-1734-6. Epub 2010 Feb 24.

DOI:10.1007/s00330-010-1734-6
PMID:20179939
Abstract

OBJECTIVE

To evaluate diffusion-weighted (DWI) magnetic resonance imaging (MRI) for treatment prediction during chemoradiotherapy (CRT) of head and neck squamous cell carcinoma (HNC).

METHODS

Thirty patients with HNC underwent echo-planar DWI and anatomical MRI before and 2 and 4 weeks into CRT. Patient follow-up lasted 2 years post-CRT. Tumour ADC (DeltaADC) and volume changes (DeltaV) between baseline, and 2 and 4 weeks' follow-up were compared for lesions with recurrence versus complete remission (CR) using a Mann-Whitney U test. The predictive value of the DeltaADC and DeltaV for locoregional control (LRC) was examined with the Kaplan-Meier method. The study was approved by the local ethics committee. All patients gave written informed consent.

RESULTS

The DeltaADC in primary tumours and nodal metastases, 2 and 4 weeks after the start of CRT, was significantly lower in lesions with post-CRT recurrence than in lesions with CR (DeltaADC(2 weeks) and DeltaADC(4 weeks) for primary tumours, relative to nodal metastases: p < 0.0001). The DeltaV only showed a significant difference for primary tumours at 2 weeks (DeltaV(2 weeks): p = 0.03). The DeltaADC correlated significantly with 2-year LRC (p < 0.001); the DeltaV did not (p > 0.05).

CONCLUSION

DWI during CRT for HNC allows more accurate response prediction than anatomical imaging, correlating significantly with 2-year LRC.

摘要

目的

评估弥散加权(DWI)磁共振成像(MRI)对头颈部鳞状细胞癌(HNC)放化疗期间的治疗预测作用。

方法

30 例 HNC 患者在放化疗前及 2 周和 4 周时进行了 echo-planar DWI 和解剖学 MRI。患者的随访时间为放化疗后 2 年。采用 Mann-Whitney U 检验比较复发与完全缓解(CR)患者的基线、2 周和 4 周时的肿瘤 ADC(DeltaADC)和体积变化(DeltaV)。用 Kaplan-Meier 法检验 DeltaADC 和 DeltaV 对局部区域控制(LRC)的预测价值。本研究经当地伦理委员会批准,所有患者均签署了书面知情同意书。

结果

放化疗开始后 2 周和 4 周时,原发灶和淋巴结转移灶的 DeltaADC 在复发组明显低于 CR 组(原发灶的 DeltaADC(2 周)和 DeltaADC(4 周),相对于淋巴结转移灶:p < 0.0001)。DeltaV 仅在 2 周时原发灶有显著差异(DeltaV(2 周):p = 0.03)。DeltaADC 与 2 年 LRC 显著相关(p < 0.001);DeltaV 无相关性(p > 0.05)。

结论

HNC 放化疗期间的 DWI 比解剖学成像能更准确地预测反应,与 2 年 LRC 显著相关。

相似文献

1
Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma.磁共振弥散加权成像在头颈部鳞癌放化疗中的预测价值。
Eur Radiol. 2010 Jul;20(7):1703-14. doi: 10.1007/s00330-010-1734-6. Epub 2010 Feb 24.
2
Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.放化疗后早期磁共振弥散加权成像监测头颈部鳞癌治疗反应
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1098-107. doi: 10.1016/j.ijrobp.2011.02.044. Epub 2011 Apr 20.
3
Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.弥散加权磁共振成像对直肠癌新辅助放化疗反应的预测及早期评估价值:初步结果。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):863-70. doi: 10.1016/j.ijrobp.2010.12.063. Epub 2011 Mar 11.
4
Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer.宫颈癌放化疗期间扩散加权磁共振成像的预测价值
J Obstet Gynaecol Res. 2014 Apr;40(4):1098-104. doi: 10.1111/jog.12276. Epub 2013 Dec 10.
5
The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.扩散加权磁共振成像(DWI)可预测食管鳞状细胞癌对同步放化疗的早期反应。
Radiother Oncol. 2016 Nov;121(2):246-251. doi: 10.1016/j.radonc.2016.10.021. Epub 2016 Nov 9.
6
Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.3.0T 磁共振弥散加权成像在术前放化疗治疗局部进展期直肠癌早期评估中的应用。
Abdom Radiol (NY). 2018 Sep;43(9):2221-2230. doi: 10.1007/s00261-018-1457-8.
7
Redefining the target early during treatment. Can we visualize regional differences within the target volume using sequential diffusion weighted MRI?在治疗早期重新定义目标。我们能否使用序贯扩散加权磁共振成像来可视化靶区内的区域差异?
Radiother Oncol. 2014 Feb;110(2):329-34. doi: 10.1016/j.radonc.2013.09.023. Epub 2013 Nov 11.
8
Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.弥散加权 MRI 及其表观弥散系数测量在预测局部进展期直肠癌新辅助放化疗疗效中的价值。
Abdom Radiol (NY). 2016 Oct;41(10):1906-17. doi: 10.1007/s00261-016-0805-9.
9
Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study.弥散加权磁共振预测局部进展期直肠癌新辅助放化疗后疗效的单中心前瞻性研究初步结果。
Eur J Surg Oncol. 2013 Oct;39(10):1071-8. doi: 10.1016/j.ejso.2013.07.090. Epub 2013 Aug 15.
10
Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology.评估胃食管交界癌新辅助治疗反应的表观扩散系数改变:与组织学肿瘤退缩分级的比较。
Eur Radiol. 2013 Aug;23(8):2165-74. doi: 10.1007/s00330-013-2807-0. Epub 2013 Apr 16.

引用本文的文献

1
DWI-guided DP-IMRT and conventional MRI-based IMRT in head and neck squamous cell carcinoma: a comparative study.弥散加权成像引导的调强适形放疗与基于传统磁共振成像的调强适形放疗在头颈部鳞状细胞癌中的比较研究
BMC Cancer. 2025 Aug 23;25(1):1364. doi: 10.1186/s12885-025-14684-x.
2
The use of diffusion-weighted magnetic resonance imaging and parametric response mapping for disease outcome prediction in nasopharyngeal carcinoma.利用扩散加权磁共振成像和参数反应映射预测鼻咽癌的疾病转归
BMC Med Imaging. 2025 Jul 31;25(1):308. doi: 10.1186/s12880-025-01847-2.
3
Role of Diffusion Weighted Magnetic Resonance Imaging in Oral Cancer in Predicting Response to Neoadjuvant Chemotherapy.

本文引用的文献

1
Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.用于预测和检测头颈部鳞状细胞癌放化疗早期反应的扩散加权磁共振成像
Clin Cancer Res. 2009 Feb 1;15(3):986-94. doi: 10.1158/1078-0432.CCR-08-1287.
2
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.磁共振扩散加权成像作为一种癌症生物标志物:共识与建议
Neoplasia. 2009 Feb;11(2):102-25. doi: 10.1593/neo.81328.
3
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.
扩散加权磁共振成像在口腔癌中预测新辅助化疗反应的作用
Indian J Otolaryngol Head Neck Surg. 2025 Jun;77(6):2352-2362. doi: 10.1007/s12070-025-05511-7. Epub 2025 May 2.
4
Improving outcome prediction in oropharyngeal carcinoma through the integration of diffusion-weighted magnetic resonance imaging radiomics.通过整合扩散加权磁共振成像放射组学改善口咽癌的预后预测
Phys Imaging Radiat Oncol. 2025 Mar 31;34:100759. doi: 10.1016/j.phro.2025.100759. eCollection 2025 Apr.
5
Change in diffusion weighted imaging after induction chemotherapy outperforms RECIST guideline for long-term outcome prediction in advanced nasopharyngeal carcinoma.诱导化疗后弥散加权成像的变化在预测晚期鼻咽癌长期预后方面优于RECIST指南。
Cancer Imaging. 2025 Mar 12;25(1):32. doi: 10.1186/s40644-025-00854-4.
6
Diffusion-Weighted MRI and Human Papillomavirus (HPV) Status in Oropharyngeal Cancer.口咽癌的扩散加权磁共振成像与人类乳头瘤病毒(HPV)状态
Cancers (Basel). 2024 Dec 23;16(24):4284. doi: 10.3390/cancers16244284.
7
Conference Report: Review of Clinical Implementation of Advanced Quantitative Imaging Techniques for Personalized Radiotherapy.会议报告:高级定量成像技术在个性化放疗临床应用中的回顾。
Tomography. 2024 Nov 14;10(11):1798-1813. doi: 10.3390/tomography10110132.
8
Reduced-distortion diffusion weighted imaging for head and neck radiotherapy.用于头颈部放射治疗的低失真扩散加权成像
Phys Imaging Radiat Oncol. 2024 Sep 23;32:100653. doi: 10.1016/j.phro.2024.100653. eCollection 2024 Oct.
9
Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinoma.头颈部癌治疗反应的预测标志物:鼻咽癌中的T1rho成像
Eur Radiol. 2025 Mar;35(3):1265-1275. doi: 10.1007/s00330-024-10948-5. Epub 2024 Aug 27.
10
Diffusion-weighted magnetic resonance imaging as an early prognostic marker of chemoradiotherapy response in squamous cell carcinoma of the anus: An individual patient data -analysis.扩散加权磁共振成像作为肛门鳞状细胞癌放化疗反应的早期预后标志物:一项个体患者数据分析
Phys Imaging Radiat Oncol. 2024 Jul 31;31:100618. doi: 10.1016/j.phro.2024.100618. eCollection 2024 Jul.
同步使用紫杉醇和放疗治疗局部晚期头颈癌的长期疗效和毒性
Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1040-6. doi: 10.1016/j.ijrobp.2008.09.053. Epub 2008 Dec 29.
4
Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck.弥散磁共振成像:头颈部鳞状细胞癌小鼠模型中放化疗反应的成像治疗生物标志物。
Transl Oncol. 2008 Dec;1(4):187-94. doi: 10.1593/tlo.08166.
5
Diffusion-weighted magnetic resonance imaging in neck lymph adenopathy.颈部淋巴结病的磁共振扩散加权成像
Cancer Imaging. 2008 Sep 30;8(1):173-80. doi: 10.1102/1470-7330.2008.0025.
6
Targeted therapies in head and neck cancer: past, present and future.头颈部癌症的靶向治疗:过去、现在与未来
Rev Recent Clin Trials. 2008 Sep;3(3):156-66. doi: 10.2174/157488708785700285.
7
Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer.扩散加权磁共振成像在宫颈癌放化疗反应早期检测中的应用
Gynecol Oncol. 2008 Nov;111(2):213-20. doi: 10.1016/j.ygyno.2008.07.048. Epub 2008 Sep 6.
8
Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody.乳腺肿瘤异种移植:采用扩散加权磁共振成像评估新型诱导凋亡抗DR5抗体的早期治疗效果
Radiology. 2008 Sep;248(3):844-51. doi: 10.1148/radiol.2483071740.
9
Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.同步化疗加超分割加速放疗对晚期头颈部鳞状细胞癌的影响。
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1088-95. doi: 10.1016/j.ijrobp.2008.05.042. Epub 2008 Aug 15.
10
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.功能扩散图谱作为高级别胶质瘤的早期影像生物标志物:与传统放射学反应及总生存期的相关性
J Clin Oncol. 2008 Jul 10;26(20):3387-94. doi: 10.1200/JCO.2007.15.2363. Epub 2008 Jun 9.